Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Ensign Group Q2 profit beats on higher occupancy rates

Ensign Group Q2 profit beats on higher occupancy rates

ReutersReuters2026/07/27 10:17
By:Reuters


Overview

  • US skilled nursing operator's Q2 revenue rose 17%, adjusted EPS beat analyst expectations

  • Adjusted EPS for Q2 rose 21% year-over-year, beating consensus

  • Company raised 2026 annual earnings and revenue guidance after strong Q2 results


Outlook

  • Ensign raises 2026 annual EPS guidance to $7.75-$7.85 from $7.48-$7.62

  • Company raises 2026 annual revenue guidance to $5.87 bln-$5.92 bln from $5.81 bln-$5.86 bln

  • Company expects to maintain a healthy pace of acquisitions through Q3 2026


Result Drivers

  • OCCUPANCY AND SKILLED MIX - Higher occupancy rates and increased skilled mix revenue and days drove growth, per CEO Barry Port

  • ACQUISITIONS - Addition of 20 new operations, including real estate assets, contributed to revenue growth, per Chief Investment Officer Chad Keetch

  • CLINICAL OUTCOMES - Superior CMS quality ratings and lower rehospitalization rates supported demand and financial results


Company press release: ID:nGNX45dC0G


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Rental Revenue

$7.98 mln

Q2 Adjusted EPS

Beat

$1.92

$1.84 (4 Analysts)

Q2 EPS

$1.68

Q2 Net Income

$99.83 mln

Q2 Operating Income

$122.50 mln

Q2 Service Revenue

$1.43 bln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities services peer group is "buy"

  • Wall Street's median 12-month price target for Ensign Group, Inc is $222.38, about 28.6% above its July 24 closing price of $172.99

  • The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 26 three months ago


Reuters Recommended Reads

  • July 24 - HCA Healthcare Q2 revenue rises on Medicaid programs; narrows outlook

  • July 25 - US measles cases hit 35-year high as vaccinations decline

  • July 24 - US FDA approves over-the-counter Tylenol combination pill for pain relief


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!